Medication errors in a pediatric emergency department

被引:87
作者
Selbst, SM [1 ]
Fein, JA [1 ]
Osterhoudt, K [1 ]
Ho, W [1 ]
机构
[1] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA
关键词
medication errors; iatrogenic injuries;
D O I
10.1097/00006565-199902000-00001
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To initiate investigation into the medication errors that occur in a pediatric emergency department. These errors have the potential for significant morbidity and mortality, as well as costly litigation. Methods: We conducted a retrospective chart review of all medication and intravenous fluid errors identified in a pediatric emergency department through incident reports filed over a 5-year period. An attempt was made to determine who was involved with the errors and what caused the errors. The patient outcomes were noted and classified according to clinical significance using previously published criteria. Results: Thirty-three incident reports involving medication or intravenous fluid errors were analyzed, Most errors occurred on the evening and night shifts, Nurses were involved in 39% of reported errors; the nurse and emergency physician were jointly involved in 36%, The most common error was an incorrect dose of medication (35%) or incorrect medication given (30%). In one third of the cases, the family was not made aware of the error. In 12%, patients required additional treatment, and one was admitted to the hospital because of the error. There were no deaths. Conclusion: Incorrect recording of patient weights leading to an incorrect medication dose and failure to note drug allergy are common causes for medication errors in the pediatric emergency department. Incorrect drugs and IV fluids are given because of similar names and packaging. Many of the errors in the ED seem to be preventable.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 15 条
[1]  
American Society of Hospital Pharmacists, 1993, AM J HOSP PHARM, V50, P305
[2]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[3]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[4]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851
[5]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306
[6]  
FOLLI HL, 1987, PEDIATRICS, V79, P718
[7]  
JONVILLE APE, 1991, DICP ANN PHARMAC, V25, P1113
[8]   MULTIDISCIPLINARY PROGRAM FOR DETECTING AND EVALUATING ADVERSE DRUG-REACTIONS [J].
KEITH, MR ;
BELLANGERMCCLEERY, RA ;
FUCHS, JE .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (09) :1809-1812
[9]  
KOREN G, 1986, PEDIATRICS, V77, P848
[10]   SYSTEMS-ANALYSIS OF ADVERSE DRUG EVENTS [J].
LEAPE, LL ;
BATES, DW ;
CULLEN, DJ ;
COOPER, J ;
DEMONACO, HJ ;
GALLIVAN, T ;
HALLISEY, R ;
IVES, J ;
LAIRD, N ;
LAFFEL, G ;
NEMESKAL, R ;
PETERSEN, LA ;
PORTER, K ;
SERVI, D ;
SHEA, BF ;
SMALL, SD ;
SWEITZER, BJ ;
THOMPSON, BT ;
VANDERVLIET, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :35-43